Predicting sPTB Early: What Do We Do Now?
The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.
Predicting sPTB Early: What Do We Do Now?
With the tools available to us today, physicians are unable to predict the large majority of women who will eventually deliver preterm. Now we have a proteomic predictor – which also provides the beginning of greater understanding of pathways.
The objective if this discussion is to look at some of the implications of having an objective predictor. What do we do differently? In what ways can this make a greater difference in our fight against preterm birth? We also need to address some of the uncertainties that exist when we know a woman is at risk for preterm birth.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
